News & Media
TheraCell and AlloSource Announce Second Patent for Bone Fiber Technology
Northridge, Calif. and Centennial, Colo. — Mar. 9, 2017 — TheraCell, a regenerative medicine company, today announced it was awarded a second patent for its demineralized bone fiber (DBF™) technology by the United States Patent and Trademark Office. The addition of U.S. Patent Number 9,572,912, titled Demineralized bone fibers having controlled geometry and shapes and methods thereof, expands TheraCell’s intellectual property portfolio, demonstrating its ongoing commitment to innovation and leadership in the orthopedic allograft industry.
TheraCell and AlloSource Announce Issuance of Patent for Bone Fiber Technology
Northridge, Calif. and Centennial, Colo. — Oct. 25, 2016 — TheraCell, a regenerative medicine company, today announced that the United States Patent and Trademark Office (USPTO) will issue TheraCell a patent for its demineralized bone fiber (DBF™) technology. The addition of this patent expands TheraCell’s patent portfolio, demonstrating its ongoing commitment to innovation and leadership in the orthopedic allograft industry.
Theracell, Inc. (Los Angeles) announces appointment of Dr. Gunnar Andersson to its Board of Directors and Surgeon Advisory Board.
LOS ANGELES, May 21, 2015 -- The Board of Directors of Theracell, Inc. today announced the appointment of Dr. Gunnar B.J. Andersson, MD PhD, a world-renowned spine surgeon as a director of the company and member of the its surgeon advisory board, effective immediately. Dr. Andersson’s appointment expands the Board to 5 directors. Two of the company’s five directors are spine surgeons.
TheraCell has a partnership with a large US tissue bank who have licensed manufacturing and distribution rights to certain Theracell products. They are one of the leading tissue banks world wide and offer more than 200 types of precise bone, skin, soft-tissue and custom-machined allografts for use in an array of life-saving and life-enhancing medical procedures.
TheraCell believes strongly in the power of partnerships to progress science and product development and seeks mutually rewarding partnerships. We currently have non exclusive partnerships with companies who are evaluating the synergy between TheraCell’s DBF™ fibers and growth factors and autologous cell therapy products.
Contact us to discuss partnering your technology, or any other partnership opportunities.